Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats

Psychoneuroendocrinology

Volumn 45, Issue , 2014, Pages 31-42

  Sabihi, Sara ^a   Durosko, Nicole E ^a   Dong, Shirley M ^a   Leuner, Benedetta ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Anxiety; Medial prefrontal cortex; Oxytocin; Prelimbic; Sex differences; Vasopressin

Indexed keywords

ARGIPRESSIN; OXYTOCIN; OXYTOCIN RECEPTOR; ANXIOLYTIC AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; FEMALE; MALE; NONHUMAN; PREFRONTAL CORTEX; PRELIMBIC MEDIAL PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEX DIFFERENCE; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; DOWN REGULATION; DRUG EFFECTS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; PREVENTION AND CONTROL; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DOWN-REGULATION; FEMALE; INFUSIONS, INTRAVENTRICULAR; MALE; OXYTOCIN; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OXYTOCIN;

EID: 84901238796     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.03.009     Document Type: Article

References (99)

1. Argiolas A., Melis M.R. The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals. Physiol. Behav. 2004, 83:309-317.
2. Ayers L.W., Missig G., Schulkin J., Rosen J.B. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm: peripheral vs central administration. Neuropsychopharmacology 2011, 36:2488-2497.
3. Bale T.L., Davis A.M., Auger A.P., Dorsa D.M., McCarthy M.M. CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J. Neurosci. 2001, 21:2546-2552.
4. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 2011, 15:301-309.
5. Benarroch E.E. Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions. Neurology 2013, 80:1521-1528.
6. Bhatnagar S., Sun L.M., Raber J., Maren S., Julius D., Dallman M.F. Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol. Behav. 2004, 81:545-555.
7. Bi L.L., Wang J., Luo Z.Y., Chen S.P., Geng F., Chen Y.H., Li S.J., Yuan C.H., Lin S., Gao T.M. Enhanced excitability in the infralimbic cortex produces anxiety-like behaviors. Neuropharmacology 2013, 72C:148-156.
8. Bissiere S., Plachta N., Hoyer D., McAllister K.H., Olpe H.R., Grace A.A., Cryan J.F. The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning. Biol. Psychiatry 2008, 63:821-831.
9. Blume A., Bosch O.J., Miklos S., Torner L., Wales L., Waldherr M., Neumann I.D. Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur. J. Neurosci. 2008, 27:1947-1956.
10. Bosch O.J., Neumann I.D. Both oxytocin and vasopressin are mediators of maternal care and aggression in rodents: from central release to sites of action. Horm. Behav. 2012, 61:293-303.
11. Carter C.S. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders?. Behav. Brain Res. 2007, 176:170-186.
12. Chini B., Mouillac B., Balestre M.N., Trumpp-Kallmeyer S., Hoflack J., Hibert M., Andriolo M., Pupier S., Jard S., Barberis C. Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett. 1996, 397:201-206.
13. Choleris E., Devidze N., Kavaliers M., Pfaff D.W. Steroidal/neuropeptide interactions in hypothalamus and amygdala related to social anxiety. Prog. Brain Res. 2008, 170:291-303.
14. Covington H.E., Lobo M.K., Maze I., Vialou V., Hyman J.M., Zaman S., LaPlant Q., Mouzon E., Ghose S., Tamminga C.A., Neve R.L., Deisseroth K., Nestler E.J. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J. Neurosci. 2010, 30:16082-16090.
15. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 1994, 49:171-176.
16. De Almeida R.M., Giovenardi M., Charchat H., Lucion A.B. 8-OH-DPAT in the median raphe nucleus decreases while in the medial septal area it may increase anxiety in female rats. Neurosci. Biobehav. Rev. 1998, 23:259-264.
17. de Oliveira D.C., Chagas M.H., Garcia L.V., Crippa J.A., Zuardi A.W. Oxytocin interference in the effects induced by inhalation of 7.5% CO(2) in healthy volunteers. Hum. Psychopharmacol. 2012, 27:378-385.
18. De Vries G.J. Minireview: sex differences in adult and developing brains: compensation, compensation, compensation. Endocrinology 2004, 145:1063-1068.
19. Dumais K.M., Bredewold R., Mayer T.E., Veenema A.H. Sex differences in oxytocin receptor binding in forebrain regions: correlations with social interest in brain region- and sex- specific ways. Horm. Behav. 2013, 64:693-701.
20. Engelmann M., Ebner K., Wotjak C.T., Landgraf R. Endogenous oxytocin is involved in short-term olfactory memory in female rats. Behav. Brain Res. 1998, 90:89-94.
21. Everett J.W. Neurobiology of reproduction in the female rat. A fifty-year perspective. Monogr. Endocrinol. 1989, 32:1-133.
22. Figueira R.J., Peabody M.F., Lonstein J.S. Oxytocin receptor activity in the ventrocaudal periaqueductal gray modulates anxiety-related behavior in postpartum rats. Behav. Neurosci. 2008, 122:618-628.
23. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods 1980, 2:219-238.
24. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
25. Gonzalez L.E., Rujano M., Tucci S., Paredes D., Silva E., Alba G., Hernandez L. Medial prefrontal transection enhances social interaction I: behavioral studies. Brain Res. 2000, 887:7-15.
26. Gould B.R., Zingg H.H. Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-LacZ reporter mouse. Neuroscience 2003, 122:155-167.
27. Grillon C., Krimsky M., Charney D.R., Vytal K., Ernst M., Cornwell B. Oxytocin increases anxiety to unpredictable threat. Mol. Psychiatry 2012, 18:958-960.
28. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., Hickie I.B. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 2010, 67:692-694.
29. Guzman Y.F., Tronson N.C., Jovasevic V., Sato K., Guedea A.L., Mizukami H., Nishimori K., Radulovic J. Fear-enhancing effects of septal oxytocin receptors. Nat. Neurosci. 2013, 16:1185-1187.
30. Hamani C., Diwan M., Isabella S., Lozano A.M., Nobrega J.N. Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats. J. Psychiatr. Res. 2010, 44:683-687.
31. Heidbreder C.A., Groenewegen H.J. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci. Biobehav. Rev. 2003, 27:555-579.
32. Heinrichs M., Baumgartner T., Kirschbaum C., Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 2003, 54:1389-1398.
33. Heinrichs M., von Dawans B., Domes G. Oxytocin, vasopressin, and human social behavior. Front. Neuroendocrinol. 2009, 30:548-557.
34. Hicks C., Jorgensen W., Brown C., Fardell J., Koehbach J., Gruber C.W., Kassiou M., Hunt G.E., McGregor I.S. The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats. J. Neuroendocrinol. 2012, 24:1012-1029.
35. Hiroi R., Neumaier J.F. Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle. Behav. Brain Res. 2006, 166:93-100.
36. Hoge E.A., Pollack M.H., Kaufman R.E., Zak P.J., Simon N.M. Oxytocin levels in social anxiety disorder. CNS Neurosci. Ther. 2008, 14:165-170.
37. Hoover W.B., Vertes R.P. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct. Funct. 2007, 212:149-179.
38. Insel T.R., Shapiro L.E. Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:5981-5985.
39. Jinks A.L., McGregor I.S. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res. 1997, 772:181-190.
40. Johnston A.L., File S.E. Sex differences in animal tests of anxiety. Physiol. Behav. 1991, 49:245-250.
41. Kanat M., Heinrichs M., Domes G. Oxytocin and the social brain: neural mechanisms and perspectives in human research. Brain Res. 2013, 10.1016/j.brainres.2013.11.003.
42. Kim S.S., Wang H., Li X.Y., Chen T., Mercaldo V., Descalzi G., Wu L.J., Zhuo M. Neurabin in the anterior cingulate cortex regulates anxiety-like behavior in adult mice. Mol. Brain 2011, 4:6.
43. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., Osten P., Schwarz M.K., Seeburg P.H., Stoop R., Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
44. Lacroix L., Spinelli S., Heidbreder C.A., Feldon J. Differential role of the medial and lateral prefrontal cortices in fear and anxiety. Behav. Neurosci. 2000, 114:1119-1130.
45. Lapiz-Bluhm M.D., Bondi C.O., Doyen J., Rodriguez G.A., Bedard-Arana T., Morilak D.A. Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J. Neuroendocrinol. 2008, 20:1115-1137.
46. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., Koenig J.I. Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin. Brain Res. 2007, 1156:152-167.
47. Lim M.M., Young L.J. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm. Behav. 2006, 50:506-517.
48. Liu W., Pappas G.D., Carter C.S. Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (±) reeler mice. Neurol. Res. 2005, 27:339-345.
49. Ludwig M., Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 2006, 7:126-136.
50. Lukas M., Toth I., Reber S.O., Slattery D.A., Veenema A.H., Neumann I.D. The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 2011, 36:2159-2168.
51. Maaswinkel H., Gispen W.H., Spruijt B.M. Effects of an electrolytic lesion of the prelimbic area on anxiety-related and cognitive tasks in the rat. Behav. Brain Res. 1996, 79:51-59.
52. Mak P., Broussard C., Vacy K., Broadbear J.H. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. J. Psychopharmacol. 2012, 26:532-542.
53. Mantella R.C., Vollmer R.R., Li X., Amico J.A. Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 2003, 144:2291-2296.
54. Marcondes F.K., Miguel K.J., Melo L.L., Spadari-Bratfisch R.C. Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiol. Behav. 2001, 74:435-440.
55. Maroun M. Medial prefrontal cortex: multiple roles in fear and extinction. Neuroscientist 2012, 19:370-383.
56. McCall C., Singer T. The animal and human neuroendocrinology of social cognition, motivation and behavior. Nat. Neurosci. 2012, 15:681-688.
57. McCarthy M.M., McDonald C.H., Brooks P.J., Goldman D. An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol. Behav. 1996, 60:1209-1215.
58. Mora S., Dussaubat N., Diaz-Veliz G. Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology 1996, 21:609-620.
59. Neumann I.D. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog. Brain Res. 2002, 139:147-162.
60. Neumann I.D. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J. Neuroendocrinol. 2008, 20:858-865.
61. Neumann I.D., Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012, 35:649-659.
62. Neumann I.D., Torner L., Wigger A. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 2000, 95:567-575.
63. Ninan I. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J. Neurochem. 2011, 119:324-331.
64. Nyuyki K.D., Waldherr M., Baeuml S., Neumann I.D. Yes, I am ready now: differential effects of paced versus unpaced mating on anxiety and central oxytocin release in female rats. PLoS One 2011, 6:e23599.
65. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego, CA.
66. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14:149-167.
67. Pereira M., Morrell J.I. Functional mapping of the neural circuitry of rat maternal motivation: effects of site-specific transient neural inactivation. J. Neuroendocrinol. 2011, 23:1020-1035.
68. Popik P., van Ree J.M. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain. Eur. Neuropsychopharmacol. 1991, 1:555-560.
69. Postina R., Kojro E., Fahrenholz F. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling. Adv. Exp. Med. Biol. 1998, 449:371-385.
70. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463:3-33.
71. Qi J., Han W.Y., Yang J.Y., Wang L.H., Dong Y.X., Wang F., Song M., Wu C.F. Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain. Addict. Biol. 2012, 17:758-769.
72. Qi J., Yang J.Y., Wang F., Zhao Y.N., Song M., Wu C.F. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 2009, 56:856-865.
73. Radley J.J., Arias C.M., Sawchenko P.E. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. J. Neurosci. 2006, 26:12967-12976.
74. Ramos L., Hicks C., Kevin R., Caminer A., Narlawar R., Kassiou M., McGregor I.S. Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology 2013, 38:2249-2259.
75. Resstel L.B., Souza R.F., Guimaraes F.S. Anxiolytic-like effects induced by medial prefrontal cortex inhibition in rats submitted to the Vogel conflict test. Physiol. Behav. 2008, 93:200-205.
76. Ring R.H., Malberg J.E., Potestio L., Ping J., Boikess S., Luo B., Schechter L.E., Rizzo S., Rahman Z., Rosenzweig-Lipson S. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berlin) 2006, 185:218-225.
77. Rotzinger S., Lovejoy D.A., Tan L.A. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 2010, 31:736-756.
78. Royce J.R. On the consrtuct validity of open-field measures. Psychol. Bull. 1977, 84:1098-1106.
79. Sala M., Braida D., Lentini D., Busnelli M., Bulgheroni E., Capurro V., Finardi A., Donzelli A., Pattini L., Rubino T., Parolaro D., Nishimori K., Parenti M., Chini B. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 2011, 69:875-882.
80. Shah A.A., Sjovold T., Treit D. Inactivation of the medial prefrontal cortex with the GABAA receptor agonist muscimol increases open-arm activity in the elevated plus-maze and attenuates shock-probe burying in rats. Brain Res. 2004, 1028:112-115.
81. Shah A.A., Treit D. Excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests. Brain Res. 2003, 969:183-194.
82. Sheehan T.P., Chambers R.A., Russell D.S. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res. Brain Res. Rev. 2004, 46:71-117.
83. Sierra-Mercado D., Padilla-Coreano N., Quirk G.J. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 2011, 36:529-538.
84. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61.
85. Smeltzer M.D., Curtis J.T., Aragona B.J., Wang Z. Dopamine, oxytocin, and vasopressin receptor binding in the medial prefrontal cortex of monogamous and promiscuous voles. Neurosci. Lett. 2006, 394:146-151.
86. Sofroniew M.V. Morphology of vasopressin and oxytocin neurones and their central and vascular projections. Prog. Brain Res. 1983, 60:101-114.
87. Sripada C.S., Phan K.L., Labuschagne I., Welsh R., Nathan P.J., Wood A.G. Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex. Int. J. Neuropsychopharmacol. 2013, 16:255-260.
88. Stack A., Carrier N., Dietz D., Hollis F., Sorenson J., Kabbaj M. Sex differences in social interaction in rats: role of the immediate-early gene zif268. Neuropsychopharmacology 2010, 35:570-580.
89. Stern C.A., Do Monte F.H., Gazarini L., Carobrez A.P., Bertoglio L.J. Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest. Neuroscience 2010, 170:214-222.
90. Striepens N., Scheele D., Kendrick K.M., Becker B., Schafer L., Schwalba K., Reul J., Maier W., Hurlemann R. Oxytocin facilitates protective responses to aversive social stimuli in males. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:18144-18149.
91. Sullivan R.M., Gratton A. Behavioral effects of excitotoxic lesions of ventral medial prefrontal cortex in the rat are hemisphere-dependent. Brain Res. 2002, 927:69-79.
92. Tabak B.A., McCullough M.E., Szeto A., Mendez A.J., McCabe P.M. Oxytocin indexes relational distress following interpersonal harms in women. Psychoneuroendocrinology 2011, 36:115-122.
93. Uvnas-Moberg K., Ahlenius S., Hillegaart V., Alster P. High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol. Biochem. Behav. 1994, 49:101-106.
94. Vertes R.P. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 2004, 51:32-58.
95. Waldherr M., Neumann I.D. Centrally released oxytocin mediates mating-induced anxiolysis in male rats. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16681-16684.
96. Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007, 2:322-328.
97. Weisman O., Zagoory-Sharon O., Feldman R. Oxytocin administration alters HPA reactivity in the context of parent-infant interaction. Eur. Neuropsychopharmacol. 2013, 23:1724-1731.
98. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997, 138:2829-2834.
99. Yoshida M., Takayanagi Y., Inoue K., Kimura T., Young L.J., Onaka T., Nishimori K. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J. Neurosci. 2009, 29:2259-2271.